Veterinary Medicine Information website

CASTOMIX Lyophilisate and suspension for injection for rabbits

Authorised
  • Rabbit haemorrhagic disease virus, type 1, strain PHB 98, Inactivated
  • Myxoma virus, strain MAV, Live

Product identification

Medicine name:
CASTOMIX Lyophilisate and suspension for injection for rabbits
Active substance:
  • Rabbit haemorrhagic disease virus, type 1, strain PHB 98, Inactivated
  • Myxoma virus, strain MAV, Live
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabbit haemorrhagic disease virus, type 1, strain PHB 98, Inactivated
    1280.00
    haemagglutinating units
    /
    0.50
    millilitre(s)
  • Myxoma virus, strain MAV, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AH01
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pharmagal Bio spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmagal Bio spol. s r.o.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/045/06-S
Date of authorisation status change:
Reference member state:
  • Slovakia
Procedure number:
  • SK/V/0103/001
Concerned member states:
  • Poland

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 31/10/2025

Summary of Product Characteristics

English (PDF)
Published on: 26/04/2022
Download